Jubilant Pharmova announced that its wholly owned subsidiary in Singapore, Jubilant Pharma has on 05 March 2021 redeemed the principal
amount of US$100,000,000 out of US$300,000,000 Notes at a redemption price of 101.21875% together with the accrued interest till date. JPL had made the first early redemption of
US$100,000,000 in November 2019 and the second early redemption of US$100,000,000 on 29 January 2021.
After the redemption of US$100,000,000 on 05 March 2021, the Notes have been paid in full and no amount remains outstanding under the Notes.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
